Literature DB >> 27922673

Effects of miR-145 on the inhibition of chondrocyte proliferation and fibrosis by targeting TNFRSF11B in human osteoarthritis.

Guo-Dong Wang1, Xiao-Wei Zhao2, Yu-Ge Zhang2, Ying Kong2, Shuai-Shuai Niu2, Long-Fei Ma2, Yuan-Min Zhang2.   

Abstract

Osteoarthritis (OA) is a common cause of functional deterioration in older adults, and altered chondrogenesis is the most common pathophysiological process involved in the development of OA. MicroRNA‑145 (miR‑145) has been shown to regulate chondrocyte homeostasis. However, the function of miR‑145 in OA remains to be elucidated. In the present study, the expression levels of miR‑145 were examined in cartilage specimens from 25 patients with knee OA using reverse transcription‑quantitative polymerase chain reaction analysis. The effects of miR‑145 on the proliferation and fibrosis of the C‑20/A4 and CH8 cell lines were also investigated using 3-(4,5-dimethylth-iazol-2-yl)-2,5-diphenyltetrazolium bromide and western blot assays in vitro. The results revealed that the expression of miR-145 was decreased in the OA cartilage tissues, compared with normal cartilage tissues. The overexpression of miR‑145 by transfection of cells with miR‑145 mimics significantly inhibited C‑20/A4 and CH8 cell proliferation and fibrosis. Furthermore, tumor necrosis factor receptor superfamily, member 11b (TNFRSF11B) was identified as a direct target of miR‑145 in chondrocytes, which was confirmed using a dual‑luciferase reporter assay. The expression level of TNFRSF11B was markedly upregulated in the patients with OA, and the ectopic expression of miR‑145 was capable of suppressing the expression of TNFRSF11B. In addition, the knock down of TNFRSF11B using specific small interfering RNA also inhibited the proliferation and fibrosis of C‑20/A4 and CH8 cells in vitro. These data provide the first evidence, to the best of our knowledge, to suggest the critical function of miR‑145 in regulating the expression of TNFRSF11B, which may have important implications on the regulation of chondrocyte proliferation and fibrosis in OA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27922673     DOI: 10.3892/mmr.2016.5981

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Role of MicroRNA in Osteoarthritis.

Authors:  Mingcai Zhang; Kate Lygrisse; Jinxi Wang
Journal:  J Arthritis       Date:  2017-04-28

2.  LncRNA MALAT1/MiR-145 Adjusts IL-1β-Induced Chondrocytes Viability and Cartilage Matrix Degradation by Regulating ADAMTS5 in Human Osteoarthritis.

Authors:  Chengyao Liu; Shan Ren; Shifeng Zhao; Yandong Wang
Journal:  Yonsei Med J       Date:  2019-11       Impact factor: 2.759

Review 3.  Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis.

Authors:  Hui Kong; Ming-Li Sun; Xin-An Zhang; Xue-Qiang Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-15

4.  Integrated Analysis of lncRNA and mRNA Expression Profiles Indicates Age-Related Changes in Meniscus.

Authors:  Li-Ya Ai; Ming-Ze Du; You-Rong Chen; Peng-Yan Xia; Ji-Ying Zhang; Dong Jiang
Journal:  Front Cell Dev Biol       Date:  2022-03-10

5.  MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.

Authors:  Mareen Matz; Frederik Heinrich; Christine Lorkowski; Kaiyin Wu; Jens Klotsche; Qiang Zhang; Nils Lachmann; Pawel Durek; Klemens Budde; Mir-Farzin Mashreghi
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

Review 6.  Onset and Progression of Human Osteoarthritis-Can Growth Factors, Inflammatory Cytokines, or Differential miRNA Expression Concomitantly Induce Proliferation, ECM Degradation, and Inflammation in Articular Cartilage?

Authors:  Karen A Boehme; Bernd Rolauffs
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

7.  Changes of serum inflammatory factors and miR-145 expression in patients with osteoarthritis before and after treatment and their clinical value.

Authors:  Xiao-Zhen Wang; Wen-Xue Li
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.